Publisher
Springer International Publishing
Reference54 articles.
1. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003;111:1122–4.
2. Carvalho RS, Mahoney JA, Oliva-Hemker MM, et al. Inherent resistance to 6-thioguanine induced apoptosis correlates with disease activity in children with IBD. Gastroenterology. 2006;265:A203.
3. Markowitz J, Rosa J, Grancher K, Aiges H, Daum F. Long-term 6-mercaptopurine treatment in adolescents with Crohn’s disease. Gastroenterology. 1990;99:1347–51.
4. Verhave M, Winter HS, Grand RJ. Azathioprine in the treatment of children with inflammatory bowel disease. J Pediatr. 1990;117:809–14.
5. Weinshilboum RN, Sladek S. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyl transferase activity. Am J Hum Genet. 1980;32:651–62.